204 related articles for article (PubMed ID: 27063282)
21. Seroprevalence of pertussis among healthcare workers: A cross-sectional study from Tunisia.
Ben Fraj I; Smaoui H; Zghal M; Sassi O; Guiso N; Kechrid A
Vaccine; 2019 Jan; 37(1):109-112. PubMed ID: 30459070
[TBL] [Abstract][Full Text] [Related]
22. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
[TBL] [Abstract][Full Text] [Related]
23. Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples.
de Greeff SC; Teunis P; de Melker HE; Mooi FR; Notermans DW; Elvers B; Schellekens JF
Clin Vaccine Immunol; 2012 Sep; 19(9):1452-6. PubMed ID: 22787194
[TBL] [Abstract][Full Text] [Related]
24. Pertussis seroprevalence in korean adolescents and adults using anti-pertussis toxin immunoglobulin G.
Lee SY; Han SB; Bae EY; Kim JH; Kang JH; Park YJ; Ma SH
J Korean Med Sci; 2014 May; 29(5):652-6. PubMed ID: 24851020
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of Bordetella pertussis toxin antibodies in children and adolescents in Tunis, Tunisia.
Ben Fraj I; Zghal M; Hsairi M; Kechrid A; Smaoui H
Epidemiol Infect; 2019 Jan; 147():e199. PubMed ID: 31364527
[TBL] [Abstract][Full Text] [Related]
26. Increased susceptibility to pertussis in adults at childbearing age as determined by comparative seroprevalence study, China 2010-2016.
Zhang Y; Chen Z; Zhao J; Zhang N; Chen N; Zhang J; Li S; He Q
J Infect; 2019 Jul; 79(1):1-6. PubMed ID: 31009653
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis.
Zhu Y; Zhang W; Hu J; Luo S; Zhou Y; Tang X; Yan R; Deng X; He H
Hum Vaccin Immunother; 2024 Dec; 20(1):2341454. PubMed ID: 38695296
[TBL] [Abstract][Full Text] [Related]
28. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
[TBL] [Abstract][Full Text] [Related]
29. Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China.
He H; Yao P; Zhou Y; Deng X; Pan J
PLoS One; 2016; 11(5):e0155965. PubMed ID: 27223467
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study.
Hashemi SH; Ranjbar M; Hajilooi M; Seif-Rabiei MA; Bolandi M; Moghimi J
BMC Infect Dis; 2009 May; 9():58. PubMed ID: 19426546
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China.
Wang CQ; Zhu QR
Pediatr Infect Dis J; 2011 Jul; 30(7):593-6. PubMed ID: 21422963
[TBL] [Abstract][Full Text] [Related]
33. Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.
Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
Infect Dis (Lond); 2017 Aug; 49(8):594-600. PubMed ID: 28335677
[TBL] [Abstract][Full Text] [Related]
34. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
35. Seroepidemiology of pertussis in Hangzhou, China, during 2009-2017.
Xu Y; Xu E; Liu S; Zheng W; Zhang X; Du J; Zhang X; Wang J; Che X; Gu W; Liu Y
Hum Vaccin Immunother; 2019; 15(11):2564-2570. PubMed ID: 31116637
[No Abstract] [Full Text] [Related]
36. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.
Campbell P; McIntyre P; Quinn H; Hueston L; Gilbert GL; McVernon J
PLoS One; 2012; 7(4):e35874. PubMed ID: 22558249
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin.
Nooitgedagt JE; de Greeff SC; Elvers BH; de Melker HE; Notermans DW; van Huisseling H; Versteegh FG
Clin Infect Dis; 2009 Oct; 49(7):1086-9. PubMed ID: 19725791
[TBL] [Abstract][Full Text] [Related]
38. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.
Hallander HO; Andersson M; Gustafsson L; Ljungman M; Netterlid E
APMIS; 2009 Dec; 117(12):912-22. PubMed ID: 20078557
[TBL] [Abstract][Full Text] [Related]
39. The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study.
He H; Zhu Y; Jin M; Zhou Y; Tang X; Yan R; Deng X; Chen K
Vaccine; 2022 Nov; 40(48):6956-6962. PubMed ID: 36283895
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
Syed MA; Ahmed W; Naeem A; Bokhari H
J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
